Following previous studies, ADAMTS18 showed tumor suppressive effects by inhibiting epithelial-mesenchymal transition through inhibiting the NF-κB/AKT signaling pathway in breast cancer (43). The gene discussed is ADAMTS18; the disease is neoplasm.